National Psoriasis Foundation COVID-19 Task Force guidance for management of psoriatic disease during the pandemic: Version 2-Advances in psoriatic disease management, COVID-19 vaccines, and COVID-19 treatments Article

International Collaboration

author list

  • Gelfand, Joel M.; Armstrong, April W.; Bell, Stacie; Anesi, George L.; Blauvelt, Andrew; Calabrese, Cassandra; Dommasch, Erica D.; Feldman, Steven R.; Gladman, Dafna; Kircik, Leon; Lebwohl, Mark; Lo Re, Vincent, III; Martin, George; Merola, Joseph F.; Scher, Jose U.; Schwartzman, Sergio; Treat, James R.; Van Voorhees, Abby S.; Ellebrecht, Christoph T.; Fenner, Justine; Ocon, Anthony; Syed, Maha N.; Weinstein, Erica J.; Gondo, George; Heydon, Sue; Koons, Samantha; Ritchlin, Christopher T.

publication date

  • May 1, 2021




  • COVID-19
  • SARS-CoV-2
  • biologics
  • psoriasis
  • psoriatic arthritis
  • vaccines

start page

  • 1254

end page

  • 1268


  • 84


  • 5